Carlsmed (CARL) Current Assets (2024 - 2026)

Carlsmed (CARL) has reported Current Assets for 3 consecutive years, with $109.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets rose 137.27% year-over-year to $109.6 million; the trailing twelve-month figure through Jun 2026 stood at $109.6 million (up 137.27% YoY), and the FY2025 full-year result was $126.7 million, up 156.68% from the prior year.
• Current Assets declined to $109.6 million in Q2 2026 per CARL's latest filing, from $115.4 million in the prior quarter.
• Across five years, Current Assets topped out at $131.5 million in Q3 2025 and bottomed at $46.2 million in Q2 2025.
• Historically, Current Assets has averaged $96.4 million across 3 years, with a median of $112.5 million in 2026.
• The sharpest annual moves came in 2025 and 2026: Current Assets soared 156.68% in 2025, then soared 137.27% in 2026.
• Over 3 years, Current Assets stood at $49.4 million in 2024, then jumped by 156.68% to $126.7 million in 2025, then decreased by 13.48% to $109.6 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $109.6 million, $115.4 million, and $126.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.